Mark Sumeray

2015

In 2015, Mark Sumeray earned a total compensation of $1.8M as former Chief Medical Officer at Aegerion Pharmaceuticals, a 9% increase compared to previous year.

Compensation breakdown

Option Awards$1,053,164
Salary$405,000
Stock Awards$260,000
Other$56,965
Total$1,775,129

Sumeray received $1.1M in option awards, accounting for 59% of the total pay in 2015.

Sumeray also received $405K in salary, $260K in stock awards and $57K in other compensation.

Rankings

In 2015, Mark Sumeray's compensation ranked 5,219th out of 13,638 executives tracked by ExecPay. In other words, Sumeray earned more than 61.7% of executives.

ClassificationRankingPercentile
All
5,219
out of 13,638
62nd
Division
Manufacturing
1,930
out of 5,190
63rd
Major group
Chemicals And Allied Products
701
out of 1,854
62nd
Industry group
Drugs
557
out of 1,528
64th
Industry
Pharmaceutical Preparations
437
out of 1,182
63rd
Source: SEC filing on April 29, 2016.

Sumeray's colleagues

We found seven more compensation records of executives who worked with Mark Sumeray at Aegerion Pharmaceuticals in 2015.

2015

Marc Beer

Aegerion Pharmaceuticals

Chief Executive Officer

2015

Gregory Perry

Aegerion Pharmaceuticals

Chief Financial & Administration Officer

2015

Martha Carter

Aegerion Pharmaceuticals

Chief Regulatory Officer

2015

Mary Weger

Aegerion Pharmaceuticals

former Chief Performance Officer

2015

Mark Fitzpatrick

Aegerion Pharmaceuticals

Chief Financial Officer

2015

Sandford Smith

Aegerion Pharmaceuticals

Chief Executive Officer

2015

David Aubuchon

Aegerion Pharmaceuticals

Chief Financial Officer

In-depth

You may also like